# CME Group (CME) — Earnings

CME · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cme/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $2.99 |
| EPS estimate | $2.91 |
| EPS surprise | +2.92% |
| Revenue surprise | +1.43% |
| Revenue | $1.7B |
| Revenue estimate | $1.7B |
| Reported | Jul 22, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1156375/000115637526000047/cme-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/e48ad214-ee5b-7b11-bff1-bd7fc177bb38.html) |

CME Group reported Q2 2026 results on July 22, 2026. Earnings per share came in at $2.99, ahead of the $2.91 estimate by 2.92%. Revenue was $1.7 billion, in line with the consensus. Compared with Q2 2025, EPS rose about 1% from $2.96 and revenue was unchanged at $1.7 billion. Both were below Q1 2026, at $3.36 and $1.9 billion.

Annual EPS rose every year in the table, from $7.98 in 2022 to $9.34 in 2023, $10.26 in 2024 and $11.21 in 2025, a gain of about 40%. Annual revenue grew about 31% over the same span, from $4.9 billion to $6.4 billion. The first half of 2026 adds up to $6.35 per share, about 10% more than a year earlier. Q1 2026 set the highs in the table for both EPS and revenue. Over the last 20 quarters, CME Group topped the EPS estimate 19 times. The only miss was Q1 2025, at 0.13% below.

CME Group reported Q3 results between October 22 and October 27 in each of the past five years. That points to late October 2026 for the next report. It will show whether first-half growth carries into the third quarter.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 22, 2026 | $2.91 | $2.99 | 2.92% | $1.7B | $1.7B |
| Q1 2026 | Apr 22, 2026 | $3.34 | $3.36 | 0.51% | $1.9B | $1.9B |
| Q4 2025 | Feb 4, 2026 | $2.75 | $2.77 | 0.75% | $1.6B | $1.6B |
| Q3 2025 | Oct 22, 2025 | $2.63 | $2.68 | 1.93% | $1.5B | $1.5B |
| Q2 2025 | Jul 23, 2025 | $2.91 | $2.96 | 1.58% | $1.7B | $1.7B |
| Q1 2025 | Apr 23, 2025 | $2.80 | $2.80 | -0.13% | $1.6B | $1.6B |
| Q4 2024 | Feb 12, 2025 | $2.45 | $2.52 | 3.03% | $1.5B | $1.5B |
| Q3 2024 | Oct 23, 2024 | $2.65 | $2.68 | 1.04% | $1.6B | $1.6B |
| Q2 2024 | Jul 24, 2024 | $2.53 | $2.56 | 1.06% | $1.5B | $1.5B |
| Q1 2024 | Apr 24, 2024 | $2.45 | $2.50 | 1.99% | $1.5B | $1.5B |
| Q4 2023 | Feb 14, 2024 | $2.28 | $2.37 | 3.83% | $1.4B | $1.4B |
| Q3 2023 | Oct 25, 2023 | $2.22 | $2.25 | 1.23% | $1.3B | $1.3B |
| Q2 2023 | Jul 26, 2023 | $2.20 | $2.30 | 4.50% | $1.3B | $1.4B |
| Q1 2023 | Apr 26, 2023 | $2.37 | $2.42 | 1.90% | $1.4B | $1.4B |
| Q4 2022 | Feb 8, 2023 | $1.88 | $1.92 | 2.04% | $1.2B | $1.2B |
| Q3 2022 | Oct 26, 2022 | $1.94 | $1.98 | 2.10% | $1.2B | $1.2B |
| Q2 2022 | Jul 27, 2022 | $1.93 | $1.97 | 1.84% | $1.2B | $1.2B |
| Q1 2022 | Apr 27, 2022 | $2.00 | $2.11 | 5.29% | $1.3B | $1.3B |
| Q4 2021 | Feb 9, 2022 | $1.64 | $1.66 | 1.22% | $1.2B | $1.1B |
| Q3 2021 | Oct 27, 2021 | $1.55 | $1.60 | 3.13% | $1.1B | $1.1B |

## Frequently Asked Questions

### When did CME Group (CME) last report earnings?

CME Group last reported on Jul 22, 2026, covering fiscal Q2 2026.

### Did CME beat earnings estimates?

Yes. CME Group reported EPS of $2.99 for Q2 2026 against a $2.91 estimate — a 2.92% beat.

### How much revenue did CME report last quarter?

CME Group reported $1.7B in revenue for Q2 2026, against a consensus estimate of $1.7B.

## Similar Stocks

- [CBOE](https://www.lighthorse.io/tickers/cboe) — Cboe Global Markets, Inc. Common Stock
- [NDAQ](https://www.lighthorse.io/tickers/ndaq) — Nasdaq, Inc. - Common Stock
- [MKTX](https://www.lighthorse.io/tickers/mktx) — MarketAxess Holdings, Inc. - Common Stock
- [COIN](https://www.lighthorse.io/tickers/coin) — Coinbase Global, Inc. - Class A Common Stock
- [NVDA](https://www.lighthorse.io/tickers/nvda) — NVIDIA Corporation - Common Stock
- [ICE](https://www.lighthorse.io/tickers/ice) — Intercontinental Exchange Inc. Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).